The latter would be similar to mouse models with hematopoietic or myeloid Abca1/Abcg1 deficiency or patients with myeloproliferative diseases that are also characterized by a decrease in VLDL/LDL-cholesterol, accompanied by HSPC mobilization and splenomegaly. This evidence concerns the gene ABCA1 and myeloproliferative disorder.